Once patients with HFpEF are hospitalized for heart failure, their five-year mortality can be as high as 65 percent. While theres now robust evidence that people with HFpEF and obesity can benefit from semaglutide, the expense of the drug can often be a barrier, Shah said
On April 30, 2026, the FDA proposed to formally exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List, citing no clinical need for outsourcing facilities to compound these drugs from bulk substances
The medication works by improving insulin response when you eat and reducing appetite by slowing gastric emptying
High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
I have a doctors letter and prescription information if needed. Provide documentation when requested, but dont volunteer excessive medical details